Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is S  [Clear All Filters]
Journal Article
Chen H, Zhang B, Weir MD, Homayounfar N, Fay GGarcia, Martinho F, Lei L, Bai Y, Hu T, Xu HHK. S. mutans gene-modification and antibacterial resin composite as dual strategy to suppress biofilm acid production and inhibit caries. J Dent. 2020:103278.
Anon. (S039) ALDH-Expressing Cancer Stem Cells Are Associated With Inferior Survival in Patients With Resected Pancreatic Adenocarcinoma Treated With Adjuvant Chemoradiation. Oncology (Williston Park). 2014;28(1S).
Tu Y, Xie P, Du X, Fan L, Bao Z, Sun G, Zhao P, Chao H, Li C, Zeng A, et al. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop. J Cell Mol Med. 2019.
Cheng P, Eksioglu EA, Chen X, Kandell W, Le Trinh T, Cen L, Qi J, Sallman DA, Zhang Y, Tu N, et al. S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes. Leukemia. 2019.
Yang T, Cheng J, You J, Yan B, Liu H, Li F. S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53. Oncol Rep. 2018.
Romani R, Manni G, Donati C, Pirisinu I, Bernacchioni C, Gargaro M, Pirro M, Calvitti M, Manni G, Bagaglia F, et al. S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cells. Eur J Pharmacol. 2018.
Dillmann C, Mora J, Olesch C, Brüne B, Weigert A. S1PR4 is required for plasmacytoid dendritic cell differentiation. Biol Chem. 2015.
Wang F, Zhao S, Gu Z, Zhao X, Yang N, Guan L, Liu T, Wang L, Fang S, Zhu C, et al. S1PR5 regulates NK cell responses in preventing graft-versus-host disease while preserving graft-versus-tumour activity in a murine allogeneic haematopoietic stem cell transplantation model. Hematol Oncol. 2019.
Lee JEun, Lim MSun, Park JHyun, Park CHwan, Koh HChul. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells. Mol Neurobiol. 2015.
Ghosh J, Kobayashi M, Ramdas B, Chatterjee A, Ma P, Mali RSingh, Carlesso N, Liu Y, Plas DR, Chan RJ, et al. S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance. J Clin Invest. 2016.
Juan AH, Sartorelli V. S6K1ing to ResTOR Adipogenesis with Polycomb. Mol Cell. 2016;62(3):325-326.
Matelska D, Purta E, Panek S, Boniecki MJ, Bujnicki JM, Dunin-Horkawicz S. S6:S18 ribosomal protein complex interacts with a structural motif present in its own mRNA. RNA. 2013.
Li J-Y, Xiao T, Yi H-M, Yi H, Feng J, Zhu J-F, Huang W, Lu S-S, Zhou Y-H, Li X-H, et al. S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties. Cancer Lett. 2018.
Pontier-Bres R, Rampal P, Peyron J-F, Munro P, Lemichez E, Czerucka D. The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT Toxin. Toxins (Basel). 2015;7(11):4455-4467.
Strekalova E, Malin D, Weisenhorn EMM, Russell JD, Hoelper D, Jain A, Coon JJ, Lewis PW, Cryns VL. S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells. Breast Cancer Res Treat. 2019.
Qi H, Luo X, Zheng Y, Zhang H, Li J, Zou L, Feng L, Chen D, Shi Y, Tong C, et al. Safe Delivery for COVID-19 Infected Pregnancies. BJOG. 2020.
Finch L, Harris S, Solomou G, Sen J, Tzerakis N, Emes RD, Lane CS, Hart SR, Adams CF, Chari DM. Safe nanoengineering and incorporation of transplant populations in a neurosurgical grade biomaterial, DuraGen Plus, for protected cell therapy applications. J Control Release. 2020.
Torre A, Vertu-Ciolino D, Mazoyer C, Selva J, Lornage J, Salle B. Safeguarding Fertility With Whole Ovary Cryopreservation and Microvascular Transplantation: Higher Follicular Survival With Vitrification Than With Slow Freezing in a Ewe Model. Transplantation. 2016.
Dejosez M, Ura H, Brandt VL, Zwaka TP. Safeguards for Cell Cooperation in Mouse Embryogenesis Shown by Genome-Wide Cheater Screen. Science. 2013.
Aiuti A, Naldini L. Safer conditioning for blood stem cell transplants. Nat Biotechnol. 2016;34(7):721-723.
Sopfe J, Vigers T, Pyle L, Giller RH, Forlenza GP. Safety and Accuracy of Factory Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation. Diabetes Technol Ther. 2020.
Mariottini A, Innocenti C, Forci B, Magnani E, Mechi C, Barilaro A, Nistri R, Fani A, Saccardi R, Massacesi L, et al. Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. Eur J Neurol. 2018.
Mielcarek-Siedziuk M, Gajek K, Musiał J, Rybka B, Ryczan-Krawczyk R, Stachowiak M, Ussowicz M. Safety and efficacy of autologous mononuclear cell and stem cell apheresis in very low-weight children-Experience at a single center. J Clin Apher. 2019.
Li H, Yin L, Wang Y, Wang X, Shi M, Cao J, Yan Z, Sang W, Cheng H, Zhu F, et al. Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment. Bone Marrow Transplant. 2020.
Raut SS, Shah SA, Sharanangat VV, Shah KM, Patel KA, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, et al. Safety and Efficacy of Eltrombopag in Post-hematopoietic Stem Cell Transplantation (HSCT) Thrombocytopenia. Indian J Hematol Blood Transfus. 2015;31(4):413-415.

Pages